Analysts changed outlooks on top stocks. Raymond James downgraded ONON, Deutsche Bank downgraded ATA

Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio,

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil

HC Wainwright & Co. analyst Patrick R. Trucchio downgrades AtaiBeckley (NASDAQ:ATAI) from Buy

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are

Top Wall Street analysts changed outlook on top names. Check full changes on analyst ratings page. O

Jefferies analyst Andrew Tsai downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold and lowers th

Canaccord Genuity analyst Sumant Kulkarni downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold a

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's

GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea

Lilly will acquire AtaiBeckley in a deal worth up to $3.8 billion, adding late-stage depression ther

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto

U.S. stock futures declined on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices fell,

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

Eli Lilly and Company (NYSE:LLY) and AtaiBeckley Inc. (NASDAQ:ATAI), a clinical-stage biopharmaceuti

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7

AtaiBeckley shares jumped 64.70% after hours following reports that Eli Lilly is in talks to acquire

  On Wednesday, 479 stocks made new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.